Sign in →

Test Code ROMA1 Risk Score, if Premenopausal, Serum

Method Name

Only orderable as part of a profile. For more information see ROMA / Ovarian Malignancy Risk Algorithm.

 

Calculation

Reporting Name

Risk Score, if premenopausal

Specimen Type

Serum


Specimen Required


 


Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Frozen (preferred) 84 days
  Refrigerated  48 hours

Reference Values

Only orderable as part of a profile. For more information see ROMA / Ovarian Malignancy Risk Algorithm.

 

Premenopausal:<1.14 (low risk)

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

Not Applicable

LOINC Code Information

Test ID Test Order Name Order LOINC Value
ROMA1 Risk Score, if premenopausal 69569-2

 

Result ID Test Result Name Result LOINC Value
ROMA1 Risk Score, if premenopausal 69569-2

Useful For

Calculating risk assessment for finding an ovarian malignancy during surgery in premenopausal women who present with an adnexal mass

Clinical Information

Women with ovarian cancer symptoms and adnexal masses present primarily to gynecologists, primary care physicians, or general surgeons. Triage guidelines from the American College of Obstetricians and Gynecologists and the Society of Gynecologic Oncologists recommend referral of women with a pelvic mass at high risk for ovarian cancer to gynecologic oncologists. Specialized treatment improves patient outcomes resulting in fewer complications and better survival rates when compared to patients treated by surgeons less familiar with the management of ovarian cancer.

 

The risk of ovarian malignancy algorithm (ROMA) incorporates cancer antigen 125 (CA125), human epididymal protein 4 (HE4), and menopausal status to assign women that present with an adnexal mass into a high-risk or low-risk group for finding an ovarian malignancy. ROMA is indicated for women who meet the following criteria: older than age 18, presenting with an adnexal mass for which surgery is planned, and who have not yet been referred to an oncologist. ROMA must be interpreted in conjunction with clinical and radiological assessment

Interpretation

In premenopausal women, a risk of ovarian malignancy algorithm (ROMA) value of 1.14 or greater indicates a high risk of finding epithelial ovarian cancer, whereas a ROMA value less than 1.14 indicates a low risk of finding epithelial ovarian cancer at surgery.

 

The use of these cutpoints provides a 75% specificity and sensitivity of 84% in patients with stage I-IV epithelial ovarian cancer.

Cautions

No significant cautionary statements

Day(s) Performed

Monday through Friday

Report Available

1 to 3 days